Capital International Investors 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 11:58 am Purchase |
2024-04-10 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 8,223,994 10.200% |
1,803,258 (+28.08%) |
Filing |
| 2024-02-09 6:03 pm Purchase |
2024-02-07 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 6,420,736 8.100% |
860,244 (+15.47%) |
Filing |
| 2023-02-13 3:54 pm Purchase |
2023-02-14 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 5,560,492 7.100% |
1,854,488 (+50.04%) |
Filing |
| 2022-02-11 11:19 am Sale |
2022-02-14 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 3,706,004 4.800% |
-558,998 (-13.11%) |
Filing |
| 2021-08-10 12:28 pm Sale |
2021-08-10 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 4,265,002 5.600% |
-3,361,353 (-44.08%) |
Filing |
| 2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 7,626,355 10.700% |
106,552 (+1.42%) |
Filing |
| 2020-09-11 11:04 am Unchanged |
2020-09-10 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 7,519,803 10.700% |
0 (Unchanged) |
Filing |
| 2020-09-10 2:54 pm Purchase |
2020-09-10 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 7,519,803 10.700% |
7,519,803 (New Position) |
Filing |